Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection
Authors
Keywords
Immune Activation, Sustained Virologic Response, Rifaximin, Sevelamer, Pirfenidone
Journal
DRUGS
Volume 76, Issue 5, Pages 533-549
Publisher
Springer Nature
Online
2016-02-25
DOI
10.1007/s40265-016-0546-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Soluble CD14 is a nonspecific marker of monocyte activation
- (2015) Carey L. Shive et al. AIDS
- The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation
- (2015) Nikolas Itaru Wada et al. AIDS
- Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation
- (2015) David A. Zidar et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Rosuvastatin Reduces Vascular Inflammation and T-cell and Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy
- (2015) Nicholas T. Funderburg et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Effect of Probiotics (Saccharomyces boulardii) on Microbial Translocation and Inflammation in HIV-Treated Patients
- (2015) Judit Villar-García et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The Interplay Between Host Genetic Variation, Viral Replication, and Microbial Translocation in Untreated HIV-Infected Individuals
- (2015) Molly R. Perkins et al. JOURNAL OF INFECTIOUS DISEASES
- Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study
- (2015) Jean-Michel Molina et al. LANCET
- Innate immunity against HIV-1 infection
- (2015) Marcus Altfeld et al. NATURE IMMUNOLOGY
- HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment
- (2015) Avi Z. Rosenberg et al. Nature Reviews Nephrology
- Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial
- (2015) Janet Lo et al. Lancet HIV
- Latent and Active Tuberculosis Infection Increase Immune Activation in Individuals Co-Infected with HIV
- (2015) Zuri A. Sullivan et al. EBioMedicine
- Is Impact of Statin Therapy on All-Cause Mortality Different in HIV-Infected Individuals Compared to General Population? Results from the FHDH-ANRS CO4 Cohort
- (2015) Sylvie Lang et al. PLoS One
- Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial
- (2015) Steven F. L. van Lelyveld et al. PLoS One
- Comparison of Risk and Age at Diagnosis of Myocardial Infarction, End-Stage Renal Disease, and Non-AIDS-Defining Cancer in HIV-Infected Versus Uninfected Adults
- (2014) Keri N. Althoff et al. CLINICAL INFECTIOUS DISEASES
- Metabolic Syndrome, C-Reactive Protein, and Mortality in U.S. Blacks and Whites: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study
- (2014) Takeki Suzuki et al. DIABETES CARE
- Dyslipidemia and Cardiovascular Risk in Human Immunodeficiency Virus Infection
- (2014) Theodoros Kelesidis et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy
- (2014) J-P Routy et al. HIV MEDICINE
- Factors Associated With CD8+ T-Cell Activation in HIV-1–Infected Patients on Long-term Antiretroviral Therapy
- (2014) Lu Zheng et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection
- (2014) Mark S. Sulkowski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication
- (2014) Jan Kristoff et al. JOURNAL OF CLINICAL INVESTIGATION
- Antifibrotic Therapy in Simian Immunodeficiency Virus Infection Preserves CD4+ T-Cell Populations and Improves Immune Reconstitution With Antiretroviral Therapy
- (2014) Jacob D. Estes et al. JOURNAL OF INFECTIOUS DISEASES
- Rifaximin has a Marginal Impact on Microbial Translocation, T-cell Activation and Inflammation in HIV-Positive Immune Non-responders to Antiretroviral Therapy – ACTG A5286
- (2014) Allan R. Tenorio et al. JOURNAL OF INFECTIOUS DISEASES
- Sevelamer Does Not Decrease Lipopolysaccharide or Soluble CD14 Levels But Decreases Soluble Tissue Factor, Low-Density Lipoprotein (LDL) Cholesterol, and Oxidized LDL Cholesterol Levels in Individuals With Untreated HIV Infection
- (2014) Netanya G. Sandler et al. JOURNAL OF INFECTIOUS DISEASES
- Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection
- (2014) Peter W. Hunt et al. JOURNAL OF INFECTIOUS DISEASES
- The Immunologic Effects of Mesalamine in Treated HIV-Infected Individuals with Incomplete CD4+ T Cell Recovery: A Randomized Crossover Trial
- (2014) Ma Somsouk et al. PLoS One
- Hepatitis C can be cured globally, but at what cost?
- (2014) A. Hill et al. SCIENCE
- Hepatic inflammation and progressive liver fibrosis in chronic liver disease
- (2014) Albert J Czaja WORLD JOURNAL OF GASTROENTEROLOGY
- A Compositional Look at the Human Gastrointestinal Microbiome and Immune Activation Parameters in HIV Infected Subjects
- (2014) Ece A. Mutlu et al. PLoS Pathogens
- Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation
- (2014) Anna D. Nordell et al. Journal of the American Heart Association
- The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
- (2014) Kara W. Chew et al. Open Forum Infectious Diseases
- Predicting risk of cancer during HIV infection
- (2013) Álvaro H. Borges et al. AIDS
- Associations between immune depression and cardiovascular events in HIV infection
- (2013) Caroline A. Sabin et al. AIDS
- The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial
- (2013) P. W. Hunt et al. BLOOD
- Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America
- (2013) J. A. Aberg et al. CLINICAL INFECTIOUS DISEASES
- Microbial Translocation in the Pathogenesis of HIV Infection and AIDS
- (2013) Giulia Marchetti et al. CLINICAL MICROBIOLOGY REVIEWS
- Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study
- (2013) R Weber et al. HIV MEDICINE
- Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans
- (2013) Peter Libby et al. IMMUNITY
- Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients
- (2013) Jürgen K. Rockstroh et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Aspirin Attenuates Platelet Activation and Immune Activation in HIV-1-Infected Subjects on Antiretroviral Therapy
- (2013) Meagan O’Brien et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Long-Term Suppressive Combined Antiretroviral Treatment Does Not Normalize the Serum Level of Soluble CD14
- (2013) G. Mendez-Lagares et al. JOURNAL OF INFECTIOUS DISEASES
- Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy
- (2013) Claudio Ucciferri et al. JOURNAL OF MEDICAL VIROLOGY
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Metabolic disease in HIV infection
- (2013) Jordan E Lake et al. LANCET INFECTIOUS DISEASES
- Mucosal immunity in human and simian immunodeficiency lentivirus infections
- (2013) J M Brenchley Mucosal Immunology
- Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection
- (2013) Gilad Doitsh et al. NATURE
- PPARγ signaling and metabolism: the good, the bad and the future
- (2013) Maryam Ahmadian et al. NATURE MEDICINE
- Systematic Review of Antiretroviral-Associated Lipodystrophy: Lipoatrophy, but Not Central Fat Gain, Is an Antiretroviral Adverse Drug Reaction
- (2013) Reneé de Waal et al. PLoS One
- Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients
- (2013) Lauren E. Kushner et al. PLoS One
- Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism
- (2013) Ivan Vujkovic-Cvijin et al. Science Translational Medicine
- Relationship between CD4 cell count and serious long-term complications among HIV-positive individuals
- (2013) Amit C. Achhra et al. Current Opinion in HIV and AIDS
- Maintenance of Intestinal Th17 Cells and Reduced Microbial Translocation in SIV-infected Rhesus Macaques Treated with Interleukin (IL)-21
- (2013) Suresh Pallikkuth et al. PLoS Pathogens
- HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation
- (2013) Jason V. Baker et al. Journal of the American Heart Association
- Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery
- (2012) Marta Massanella et al. AIDS
- The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients
- (2012) Alejandro Vallejo et al. AIDS
- CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use
- (2012) Amanda Mocroft et al. AIDS
- Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection
- (2012) Marco Schunter et al. BMC Complementary and Alternative Medicine
- HIV Status, Burden of Comorbid Disease, and Biomarkers of Inflammation, Altered Coagulation, and Monocyte Activation
- (2012) K. A. Armah et al. CLINICAL INFECTIOUS DISEASES
- Sustained Virological Response to Interferon Plus Ribavirin Reduces Non-Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus
- (2012) J. Berenguer et al. CLINICAL INFECTIOUS DISEASES
- Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study
- (2012) Y. Lévy et al. CLINICAL INFECTIOUS DISEASES
- Mortality Attributable to Smoking Among HIV-1–Infected Individuals: A Nationwide, Population-Based Cohort Study
- (2012) Marie Helleberg et al. CLINICAL INFECTIOUS DISEASES
- Immunosenescence and HIV
- (2012) Steven G Deeks et al. CURRENT OPINION IN IMMUNOLOGY
- Innate Immune Recognition of HIV-1
- (2012) Akiko Iwasaki IMMUNITY
- Maraviroc Intensification of Stable Antiviral Therapy in HIV-1–Infected Patients With Poor Immune Restoration
- (2012) Lise Cuzin et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Different biological significance of sCD14 and LPS in HIV-infection: Importance of the immunovirology stage and association with HIV-disease progression markers
- (2012) MaConcepción Romero-Sánchez et al. JOURNAL OF INFECTION
- A Pilot Trial of Adding Maraviroc to Suppressive Antiretroviral Therapy for Suboptimal CD4+ T-Cell Recovery Despite Sustained Virologic Suppression: ACTG A5256
- (2012) T. J. Wilkin et al. JOURNAL OF INFECTIOUS DISEASES
- Effect of Cytomegalovirus-Induced Immune Response, Self Antigen–Induced Immune Response, and Microbial Translocation on Chronic Immune Activation in Successfully Treated HIV Type 1–Infected Patients: The ANRS CO3 Aquitaine Cohort
- (2012) Linda Wittkop et al. JOURNAL OF INFECTIOUS DISEASES
- Reduced Inflammation and Lymphoid Tissue Immunopathology in Rhesus Macaques Receiving Anti–Tumor Necrosis Factor Treatment During Primary Simian Immunodeficiency Virus Infection
- (2012) Brian Tabb et al. JOURNAL OF INFECTIOUS DISEASES
- X4 Human Immunodeficiency Virus Type 1 gp120 Promotes Human Hepatic Stellate Cell Activation and Collagen I Expression through Interactions with CXCR4
- (2012) Feng Hong et al. PLoS One
- Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals
- (2012) Daniel A. Duprez et al. PLoS One
- Angiotensin Converting Enzyme Inhibitor and HMG-CoA Reductase Inhibitor as Adjunct Treatment for Persons with HIV Infection: A Feasibility Randomized Trial
- (2012) Jason V. Baker et al. PLoS One
- COX-2 Inhibitors and Cardiovascular Risk
- (2012) C. P. Cannon et al. SCIENCE
- Lymphoid Tissue Damage in HIV-1 Infection Depletes Naïve T Cells and Limits T Cell Reconstitution after Antiretroviral Therapy
- (2012) Ming Zeng et al. PLoS Pathogens
- Downregulation of CD38 activation markers by atorvastatin in HIV patients with undetectable viral load
- (2011) Stéphane De Wit et al. AIDS
- High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors
- (2011) Elisabeth Aslangul et al. AIDS
- Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment
- (2011) Jacqueline Capeau et al. AIDS
- Projected life expectancy of people with HIV according to timing of diagnosis
- (2011) Fumiyo Nakagawa et al. AIDS
- Pathogenesis of Liver Fibrosis
- (2011) Virginia Hernandez-Gea et al. Annual Review of Pathology-Mechanisms of Disease
- Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study
- (2011) Josep M Llibre et al. ANTIVIRAL THERAPY
- Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders
- (2011) S. Piconi et al. BLOOD
- The Risk of Incident Coronary Heart Disease Among Veterans With and Without HIV and Hepatitis C
- (2011) Matthew S. Freiberg et al.
- Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
- (2011) G. Guaraldi et al. CLINICAL INFECTIOUS DISEASES
- Effect of Phosphate Binders on Serum Inflammatory Profile, Soluble CD14, and Endotoxin Levels in Hemodialysis Patients
- (2011) J. F. Navarro-Gonzalez et al. Clinical Journal of the American Society of Nephrology
- HIV and Tuberculosis: a Deadly Human Syndemic
- (2011) C. K. Kwan et al. CLINICAL MICROBIOLOGY REVIEWS
- Hydroxychloroquine: From Malaria to Autoimmunity
- (2011) Ilan Ben-Zvi et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Conventional Medical Management of Inflammatory Bowel Disease
- (2011) Daniel Burger et al. GASTROENTEROLOGY
- Maraviroc Can Improve Lipid Profiles in Dyslipidemic Patients with HIV: Results from the MERIT Trial
- (2011) A. MacInnes et al. HIV CLINICAL TRIALS
- Clinical relevance of cytomegalovirus viraemia*,†
- (2011) E Boffi El Amari et al. HIV MEDICINE
- Increased Platelet and Microparticle Activation in HIV Infection
- (2011) Elizabeth Mayne et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections
- (2011) Ming Zeng et al. JOURNAL OF CLINICAL INVESTIGATION
- A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response
- (2011) Hiroyu Hatano et al. JOURNAL OF INFECTIOUS DISEASES
- Intensification of Antiretroviral Therapy With Raltegravir or Addition of Hyperimmune Bovine Colostrum in HIV-Infected Patients With Suboptimal CD4+ T-Cell Response: A Randomized Controlled Trial
- (2011) Helen Byakwaga et al. JOURNAL OF INFECTIOUS DISEASES
- Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy
- (2011) Peter W. Hunt et al. JOURNAL OF INFECTIOUS DISEASES
- Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy
- (2011) Viktor Dahl et al. JOURNAL OF INFECTIOUS DISEASES
- T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women
- (2011) Robert C. Kaplan et al. JOURNAL OF INFECTIOUS DISEASES
- Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
- (2011) Netanya G. Sandler et al. JOURNAL OF INFECTIOUS DISEASES
- An Exploratory Trial of Cyclooxygenase Type 2 Inhibitor in HIV-1 Infection: Downregulated Immune Activation and Improved T Cell-Dependent Vaccine Responses
- (2011) F. O. Pettersen et al. JOURNAL OF VIROLOGY
- Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial
- (2011) A Gori et al. Mucosal Immunology
- Atherosclerosis: current pathogenesis and therapeutic options
- (2011) Christian Weber et al. NATURE MEDICINE
- Association between Use of HMG CoA Reductase Inhibitors and Mortality in HIV-Infected Patients
- (2011) Richard D. Moore et al. PLoS One
- Intensification of Antiretroviral Therapy with a CCR5 Antagonist in Patients with Chronic HIV-1 Infection: Effect on T Cells Latently Infected
- (2011) Carolina Gutiérrez et al. PLoS One
- Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection
- (2010) Emily S Ford et al. AIDS
- Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
- (2010) Steven A Yukl et al. AIDS
- Hepatic Fibrosis and the Renin-Angiotensin System
- (2010) Ghulam Abbas et al. AMERICAN JOURNAL OF THERAPEUTICS
- Sevelamer Decreases Systemic Inflammation in Parallel to a Reduction in Endotoxemia
- (2010) A.E.M. Stinghen et al. BLOOD PURIFICATION
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Causes of Death in HIV‐1–Infected Patients Treated with Antiretroviral Therapy, 1996–2006: Collaborative Analysis of 13 HIV Cohort Studies
- (2010) CLINICAL INFECTIOUS DISEASES
- The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
- (2010) I. Solovic et al. EUROPEAN RESPIRATORY JOURNAL
- A Meta-Analysis of Six Placebo-Controlled Trials of Thiazolidinedione Therapy for HIV Lipoatrophy
- (2010) Janet M. Raboud et al. HIV CLINICAL TRIALS
- Inflammation and Mortality in HIV-Infected Adults: Analysis of the FRAM Study Cohort
- (2010) Phyllis C Tien et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Persistent Microbial Translocation and Immune Activation in HIV‐1–Infected South Africans Receiving Combination Antiretroviral Therapy
- (2010) Edana Cassol et al. JOURNAL OF INFECTIOUS DISEASES
- Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
- (2010) Jacqueline Neuhaus et al. JOURNAL OF INFECTIOUS DISEASES
- Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
- (2010) Joseph J Eron et al. LANCET
- Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus–infected lipoatrophic men treated with pioglitazone: a pilot study
- (2010) Faidon Magkos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
- (2010) Maria J Buzón et al. NATURE MEDICINE
- Rifaximin Treatment in Hepatic Encephalopathy
- (2010) Nathan M. Bass et al. NEW ENGLAND JOURNAL OF MEDICINE
- Residual Viraemia in HIV-1-Infected Patients with Plasma Viral Load ≤20 copies/ml is Associated with Increased Blood Levels of Soluble Immune Activation Markers
- (2010) S. R. Ostrowski et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
- (2010) Rajesh T. Gandhi et al. PLOS MEDICINE
- Exposure to HIV-1 Directly Impairs Mucosal Epithelial Barrier Integrity Allowing Microbial Translocation
- (2010) Aisha Nazli et al. PLoS Pathogens
- Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment
- (2009) Richard H Haubrich et al. AIDS
- Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis
- (2009) Anthony M Mills et al. AIDS
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation
- (2009) N. T. Funderburg et al. BLOOD
- IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection
- (2009) I. Sereti et al. BLOOD
- Meta‐Analysis: Increased Mortality Associated with Hepatitis C in HIV‐Infected Persons Is Unrelated to HIV Disease Progression
- (2009) Ting‐Yi Chen et al. CLINICAL INFECTIOUS DISEASES
- Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus
- (2009) Juan Berenguer et al. HEPATOLOGY
- Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy
- (2009) ET Overton et al. HIV MEDICINE
- The Effects of Recombinant Human Leptin on Visceral Fat, Dyslipidemia, and Insulin Resistance in Patients with Human Immunodeficiency Virus-Associated Lipoatrophy and Hypoleptinemia
- (2009) Kathleen Mulligan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral‐Treated HIV Infection
- (2009) Wei Jiang et al. JOURNAL OF INFECTIOUS DISEASES
- High Levels of Chronic Immune Activation in the T-Cell Compartments of Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus Type 1 and on Highly Active Antiretroviral Therapy Are Reverted by Alpha Interferon and Ribavirin Treatment
- (2009) V. D. Gonzalez et al. JOURNAL OF VIROLOGY
- Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study
- (2009) Marguerite Guiguet et al. LANCET ONCOLOGY
- Interleukin-2 Therapy in Patients with HIV Infection
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- HIV Induces TRAIL Sensitivity in Hepatocytes
- (2009) Challagundla K. Babu et al. PLoS One
- HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy
- (2009) Maud Mavigner et al. PLoS One
- The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis
- (2008) Christina M Wyatt et al. AIDS
- CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection
- (2008) Jason V Baker et al. AIDS
- Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections
- (2008) J. M. Brenchley et al. BLOOD
- Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis
- (2008) Katriina Heikkilä et al. CANCER CAUSES & CONTROL
- Probiotics: Definition, Sources, Selection, and Uses
- (2008) Mary Ellen Sanders CLINICAL INFECTIOUS DISEASES
- Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
- (2008) S. De Wit et al. DIABETES CARE
- The Associations of Regional Adipose Tissue With Lipid and Lipoprotein Levels in HIV-Infected Men
- (2008) David Wohl et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- CD8+T Cell Activation in Women Coinfected with Human Immunodeficiency Virus Type 1 and Hepatitis C Virus
- (2008) Andrea Kovacs et al. JOURNAL OF INFECTIOUS DISEASES
- HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells
- (2008) M. Catalfamo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review
- (2008) John Danesh et al. PLOS MEDICINE
- Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
- (2008) Lewis H Kuller et al. PLOS MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started